November 19, 2012—Six influential House Democrats have asked the Government Accountability Office (GAO) to investigate whether group purchasing organization (GPO) contracting practices have caused drug shortages that, in turn, have forced hospitals and other providers to rely on compounding pharmacies to obtain medicines at reasonable cost.
The Nov. 15 request came amid hearings last week on the deadly nationwide meningitis outbreak linked to contaminated injectable drugs produced by a Massachusetts-based compounding pharmacy.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)